Percutaneous Coronary Intervention in Patients With End-Stage Liver Disease

Autor: Shilpkumar Arora, Mauricio G. Cohen, Apurva Badheka, Nileshkumar J. Patel, Ghanshyam Palamaner Subash Shantha, Abhishek Deshmukh, Alex P. Rodriguez, Vikas Singh, Cindy L. Grines, Eduardo de Marchena, Abhijit Ghatak
Rok vydání: 2016
Předmět:
Adult
Male
medicine.medical_specialty
Time Factors
Adolescent
medicine.medical_treatment
Population
Coronary Artery Disease
030204 cardiovascular system & hematology
Coronary Angiography
Coronary artery disease
End Stage Liver Disease
03 medical and health sciences
Liver disease
Young Adult
0302 clinical medicine
Percutaneous Coronary Intervention
Postoperative Complications
Internal medicine
medicine
Humans
030212 general & internal medicine
Myocardial infarction
education
Propensity Score
Survival rate
Aged
Retrospective Studies
Aged
80 and over
education.field_of_study
business.industry
Mortality rate
Percutaneous coronary intervention
Drug-Eluting Stents
Middle Aged
medicine.disease
United States
Survival Rate
Treatment Outcome
Conventional PCI
Cardiology
Female
Morbidity
Cardiology and Cardiovascular Medicine
business
Zdroj: The American journal of cardiology. 117(11)
ISSN: 1879-1913
Popis: The objective of our study was to assess patients with end-stage liver disease undergoing percutaneous coronary intervention (PCI) and determine the rates and trend of complications and in-hospital outcomes. Data were obtained from the Nationwide Inpatient Sample 2005 to 2012. We identified all PCIs performed in patients with diagnosis of cirrhosis during the study period by the International Classification of Diseases, Ninth Revision, Clinical Modification codes. Preventable procedural complications were identified by Patient Safety Indicators. Propensity scoring method was used to establish matched cohorts to control for imbalances and account for differences that may have influenced treatment outcomes. A total of 1,051,242 PCIs were performed during the study period, of these, 122,342 were done on subjects with a formal diagnosis of cirrhosis. Bare-metal stents (BMS) were more likely to be used in patients who presented with ST-elevation myocardial infarction (19.73 vs 13.58, p
Databáze: OpenAIRE
Externí odkaz: